FDA Delays Popular Nicotine Pouches Over Youth Risks
Popular nicotine pouches like Zyn and Velo remain unapproved in the US despite FDA fast-track. Agency hesitates due to rising youth use and addiction concerns.
/ 2 items
Popular nicotine pouches like Zyn and Velo remain unapproved in the US despite FDA fast-track. Agency hesitates due to rising youth use and addiction concerns.
Altria Group (MO) reports Q3 profit of $2.38B despite 3% revenue decline. Tobacco giant beats earnings expectations but faces vaping challenges and declining cigarette demand.